Completed PHASE3 INTERVENTIONAL NCT00000534

Calcium for Pre-Eclampsia Prevention (CPEP)

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Conditions Cardiovascular Diseases Eclampsia HELLP Syndrome Heart Diseases Hypertension Pre-Eclampsia Pregnancy Toxemias Vascular Diseases

Interventions calcium dietary supplements

Updated 7 times since 2017 Last updated: Mar 9, 2017 Started: Mar 31, 1991 Completion: Jun 30, 2000

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Cardiovascular Diseases and Eclampsia and is currently completed. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) leads this study, which shows 7 recorded versions since 1991 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Apr 2017 — Jun 2018 [monthly]

Completed PHASE3

▶ Show 2 earlier versions

Feb 2017 — Apr 2017 [monthly]

Completed PHASE3
Jan 2017 — Feb 2017 [monthly]

Completed PHASE3

First recorded

Mar 1991

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Data source: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.